Merck KGaA - SWOT Analysis
Merck KGaA - SWOT Analysis company profile is the essential source for top-level company data and information. Merck KGaA - SWOT Analysis examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy.
Merck KGaA is a global healthcare and chemicals company. The company offers prescription and patented drugs, and chemicals for high-tech applications. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. The company operates in 59 countries across the world. It is headquartered in Darmstadt, Germany and employed 33,062 people as of December 31, 2009. The company recorded revenues of E7,747 million ($10,804.2 million*) during the financial year (FY) ended December 2009, an increase of 2.1% over FY2008. The operating profit of the company was E620.9 million ($865.9 million*) during FY2009, a decrease of 15.1% over FY2008. The net profit was E366.3 million ($510.9 million*) in FY2009, a decrease of 0.2% over 2008. * Calculated using the constant conversion rate of E1 = $ 1.39463 for the financial year ended December 31, 2009.
Scope of the Report
Merck KGaA is a global healthcare and chemicals company. The company offers prescription and patented drugs, and chemicals for high-tech applications. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and shareholders own the remaining approximately 30%. The company operates in 59 countries across the world. It is headquartered in Darmstadt, Germany and employed 33,062 people as of December 31, 2009. The company recorded revenues of E7,747 million ($10,804.2 million*) during the financial year (FY) ended December 2009, an increase of 2.1% over FY2008. The operating profit of the company was E620.9 million ($865.9 million*) during FY2009, a decrease of 15.1% over FY2008. The net profit was E366.3 million ($510.9 million*) in FY2009, a decrease of 0.2% over 2008. * Calculated using the constant conversion rate of E1 = $ 1.39463 for the financial year ended December 31, 2009.
Scope of the Report
- Provides all the crucial information on Merck KGaA required for business and competitor intelligence needs
- Contains a study of the major internal and external factors affecting Merck KGaA in the form of a SWOT analysis as well as a breakdown and examination of leading product revenue streams of Merck KGaA
- Data is supplemented with details on Merck KGaA history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Merck KGaA
- Support sales activities by understanding your customers’ businesses better
- Understand prospective partners and suppliers
- Keep fully up to date on your competitors’ business structure, strategy and prospects
- Obtain the most up to date company information available
Contents
SWOT COMPANY PROFILE: Merck KGaAKey Facts: Merck KGaA
Company Overview: Merck KGaA
Business Description: Merck KGaA
Company History: Merck KGaA
Key Employees: Merck KGaA
Key Employee Biographies: Merck KGaA
Products & Services Listing: Merck KGaA
Products & Services Analysis: Merck KGaA
SWOT analysis: Merck KGaA
- Strengths: Merck KGaA
- Weaknesses: Merck KGaA
- Opportunities: Merck KGaA
- Threats: Merck KGaA
Company View: Merck KGaA
Top Competitors: Merck KGaA
Location and Subsidiary: Merck KGaA
- Head Office: Merck KGaA
- Other Locations and Subsidiaries: Merck KGaA Skip to top